Skip to main content
Boji Medical Technology Co., Ltd. logo

Boji Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300404 ISIN · CNE100001Y00 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,803 across all filing types
Latest filing 2026-05-18 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300404

About Boji Medical Technology Co., Ltd.

https://www.gzboji.com

Boji Medical Technology Co., Ltd. is a comprehensive contract research organization (CRO) providing full-service solutions for pharmaceutical and medical device development. The company specializes in clinical research services, including Phase I through IV clinical trials, bioequivalence studies, and post-marketing surveillance. Its service portfolio encompasses drug registration, medical writing, data management, and statistical analysis. Boji Medical supports clients through the entire product lifecycle, from preclinical research and regulatory consulting to clinical trial management and market authorization. The organization focuses on maintaining high standards of quality and compliance with international regulatory requirements, facilitating the development of innovative therapies and medical technologies for global biotechnology and pharmaceutical sectors.

Recent filings

Filing Released Lang Actions
北京市康达（广州）律师事务所关于公司2025年年度股东会法律意见书
AGM Information Classification · 87% confidence The document is a legal opinion letter from a law firm on the convening, procedures, proposals and voting results of the 2025 Annual General Meeting of Boji Medical Technology Co., Ltd. It is not an earnings release, management discussion or interim report, but rather part of the materials and documentation circulated for the company’s AGM, including detailed voting outcomes. This aligns with the definition of AGM Information (Code: AGM-R).
2026-05-18 Chinese
关于回购注销部分限制性股票通知债权人的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement by Boji Medical Technology Co., Ltd. regarding the repurchase and cancellation of restricted shares, with details on the reduction in total share capital and a creditor notification under the Company Law. This is a corporate action involving the company buying back and canceling its own shares, which fits the definition of a Transaction in Own Shares.
2026-05-18 Chinese
广发证券股份有限公司关于公司2023年向特定对象发行股票之保荐总结报告书
Share Issue/Capital Change Classification · 85% confidence The document is a detailed sponsorship summary report (“保荐总结报告书”) prepared by the underwriter (广发证券) on the company’s directed share issuance in 2023, including issuance size, price, net proceeds, regulatory approvals, and sponsor work details. It is neither a simple notice of report publication nor an interim or annual financial statement, but a substantive report on a specific equity issuance. This fits the “Share Issue/Capital Change” category (SHA) for announcements and documents related to new share issuances and capital changes.
2026-05-12 Chinese
关于为子公司提供融资担保的公告
Capital/Financing Update Classification · 85% confidence The document is a formal disclosure by a listed company (ticker 300404) regarding its board and shareholders’ approval to provide financing guarantees for subsidiaries. It outlines guarantee amounts, terms, and subsidiary financial data. This is not an earnings release, AGM materials, management change, or a published report, but an update on the company’s financing activities (providing loan guarantees). Therefore, it best fits the Capital/Financing Update category (CAP).
2026-04-24 Chinese
关于向金融机构申请融资授信额度的公告
Capital/Financing Update Classification · 85% confidence The document is titled as an announcement regarding the company’s application for financing credit facilities with banks and non-bank financial institutions. It details the proposed total credit limit, types of credit lines, collateral arrangements, and board/ shareholder authorisations. This is not a financial report or earnings release but a financing activity update. Therefore, it falls under Capital/Financing Update (Code: CAP).
2026-04-24 Chinese
关于非经营性资金占用及其他关联资金往来情况的专项审核说明
Audit Report / Information Classification · 94% confidence The document is issued by a certified public accounting firm (Guangdong Sinong CPA) under CPA auditing standards, entitled “专项审核说明” (special audit explanation) regarding non-operating fund occupation and related-party transactions for the 2025 year. It references the audit of the company’s financial statements, includes the audit procedures applied, and provides detailed audited tables. It is not merely an announcement of a report (RPA), nor a full annual or interim report. It is a standalone audit report on a specific matter in line with the “Audit Report / Information” definition.
2026-04-24 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.